Key points are not available for this paper at this time.
Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.
Merkulova et al. (Mon,) studied this question.